Steve Rees and his team at AstraZeneca are focusing on the first step of the drug discovery journey: coming up with the new ideas and targets that could lead to the new medicines of tomorrow.
All tagged AstraZeneca
Dave Michalovich: Using AI to seek out new drug targets
Dave Michalovich from Benevolent AI discusses how artificial intelligence (AI) and machine learning can help researchers figure out what might be going on in disease and home in on the best targets for new therapies.
David Goldstein: Mining the genome for medical insights
David Goldstein from Columbia University Medical Center explains how to turn the complex information within the human genome into insights that can lead to better medicines for patients.